Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
microRNA 6750 is a small, non-coding RNA that regulates gene expression primarily through post-transcriptional repression. It is found enriched in small extracellular vesicles in healthy individuals compared to patients with nasopharyngeal carcinoma, and its presence is associated with suppression of metastasis, inhibition of angiogenesis, and promotion of anti-tumor immune phenotypes in macrophages. It acts by silencing target genes, notably mannose 6-phosphate receptor (M6PR), and may play a significant role in remodeling the tumor microenvironment. While its molecular function is still being explored, miR-6750 is highlighted as a potential diagnostic and therapeutic marker for cancer progression, especially in NPC.
Post-transcriptional repression of target genes (notably directly targets mannose 6-phosphate receptor, M6PR); Inhibition of angiogenesis and metastasis via SEV-mediated transfer to macrophages and endothelial cells
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on microRNA 6750 (miR-6750).